XING Technologies

Australia · 3 Employees
We are an Australian-owned and operated cancer pathology lab that uses genetic sequencing to inform doctors and patients about precision cancer treatment options. Precision medicine offers cancer patients therapy options that are targeted specifically to their cancer. XING Genomic Services offers a range of cancer genetic tests for both newly diagnosed cancer patients and patients dealing with a recurrence of their disease. The results analysed in our lab will determine whether the genetic alterations found in your cancer match genetic changes that are associated with known therapies that may have not been previously considered by your treating doctor. Performing genetic testing is a powerful diagnostic tool that may also give you clarification of your cancer type. All clinically relevant genetic alterations and possible clinical trials will be reported in a clear and easy to read personalised XING Genomic Services report. The information surrounding your results will facilitate a discussion between you and your medical team. HRD Test This is a multi-gene test that analyses 18 genes involved in homologous recombination repair deficiency (HRD) and 8 genes that are diagnostically significant. This test is aimed at breast, ovarian, prostate, and pancreatic cancers. In addition, epigenetic causes of HRD can be interrogated by testing the BRCA1 and RAD51C gene promoters. STP Test This is a multi-gene test that analyses hotspot alterations considered to be driving mutations in solid tumours. It includes hotspots in 47 genes involved in colorectal, melanoma, thyroid, non-small cell lung, and pancreatic cancers, as well as gastro-intestinal stromal tumours (GIST) and gliomas.

概述

国家 Australia
成立时间 2017
总部 Brisbane, QLD 4000, AU
电话号码 +61 7 3160 2840
网站 http://www.xingtech.com.au
LinkedIn http://www.linkedin.com/company/xing-tech
Twitter
Facebook
员工数 3
行业 research,
简介 We are an Australian-owned and operated cancer pathology lab that uses genetic sequencing to inform doctors and patients about precision cancer treatment options. Precision medicine offers cancer patients therapy options that are targeted specifically to their cancer. XING Genomic Services offers a range of cancer genetic tests for both newly diagnosed cancer patients and patients dealing with a recurrence of their disease. The results analysed in our lab will determine whether the genetic alterations found in your cancer match genetic changes that are associated with known therapies that may have not been previously considered by your treating doctor. Performing genetic testing is a powerful diagnostic tool that may also give you clarification of your cancer type. All clinically relevant genetic alterations and possible clinical trials will be reported in a clear and easy to read personalised XING Genomic Services report. The information surrounding your results will facilitate a discussion between you and your medical team. HRD Test This is a multi-gene test that analyses 18 genes involved in homologous recombination repair deficiency (HRD) and 8 genes that are diagnostically significant. This test is aimed at breast, ovarian, prostate, and pancreatic cancers. In addition, epigenetic causes of HRD can be interrogated by testing the BRCA1 and RAD51C gene promoters. STP Test This is a multi-gene test that analyses hotspot alterations considered to be driving mutations in solid tumours. It includes hotspots in 47 genes involved in colorectal, melanoma, thyroid, non-small cell lung, and pancreatic cancers, as well as gastro-intestinal stromal tumours (GIST) and gliomas.

技术

CloudFlare Hosting

Hosting

Cloudflare DNS

Domain Name Services

Gmail

Email Providers

Google Apps

Other

Mobile Friendly

Other

常见问题

XING Technologies 在哪里?

XING Technologies 的总部位于 Brisbane, QLD 4000, AU

XING Technologies 的电话号码是多少?

XING Technologies 的电话号码是 +61 7 3160 2840

XING Technologies 的官方网站是什么?

XING Technologies 的公司官方网站是 http://www.xingtech.com.au

XING Technologies 是做什么的?

XING Technologies 的业务有哪些?

metastatic,prostate cancer,directed therapies,personalised medicine,cancer,parp,brca,cancer clinical trials,next generation screening,cdk46 inhibitors,haematology,nanotechnology,chemotherapy,ihavecancer,oncology,breast cancer,targeted therapy,recurrence,ovarian cancer,genomic testing

XING Technologies 的年收入是多少?

XING Technologies 的收入是 0美元

XING Technologies 有多少员工?

XING Technologies 有 3 名员工

XING Technologies 属于哪个行业?

XING Technologies 从事以下行业: research

XING Technologies 使用什么技术?

XING Technologies 使用的一些流行技术包括: CloudFlare Hosting,Cloudflare DNS,Gmail,Google Apps,Mobile Friendly

如何联系 XING Technologies?

XING Technologies 联系信息: 电话号码:+61 7 3160 2840, 网站:http://www.xingtech.com.au, 邮箱:m.r***@***.***.au

XING Technologies 的社交媒体链接是什么?

XING Technologies 领英:http://www.linkedin.com/company/xing-tech,fackbook:,twitte:

XING Technologies 是一家上市公司吗?

不是

XING Technologies 的最后一轮融资是什么时候?

暂无最近投资信息

谁投资 XING Technologies?

XING Technologies 有 0 家投资者,包括 。

管理层

Maria Read

Human Resources Office Manager

员工

Leo Wang

Chief Sales and Marketing Officer

Kevin Koo

Honorary Fellow/Principal Research Scientist

Kira Fitzpatrick

Genomic Services Scientist

Jemini Mali

Assay Development Scientist

Kira Fitzpatrick

Genomic Services Scientist

外贸获客 查找关键决策人

10亿+海关交易数据,1.2亿企业数据,2亿+企业联系人数据,1000千万真实采购商。覆盖200+个国家及地区,95%外贸重点拓展市场,可根据行业、经营范围等多方位挖掘目标客户。
免费试用

Top-ranked on G2 Crowd

全球B2B企业库 海关贸易数据 展会采购数据

工作更少,成就更大,销售更聪明

查找更多 B2B 联系人,丰富并验证记录
Email Address

全球B2B企业库

海关贸易数据

展会采购数据

Top-ranked on G2 Crowd

OR
Sign Up with Google